M. Brooke Bernhardt

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia”.

Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2024)10.1002/phar.4638

N/A

0.208DataRank · unranked

3 citations

Olga A. Taylor, M. Monica Gramatges, Amy E. Hughes, Mark Zobeck, Sandi L. Pruitt +20 more

Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org

Clinical and Translational Science(2023)10.1111/cts.13600

N/A

0DataRank · unranked

15 citations

Tamara P. Miller, Ethan A. Poweleit, Nicholas P. DeGroote, Lauren Pommert, Oluwafunbi Awoniyi +11 more

Ethnic‐specific predictors of neurotoxicity among patients with pediatric acute lymphoblastic leukemia after high‐dose methotrexate

Cancer(2023)10.1002/cncr.34646

N/A

0DataRank · unranked

17 citations

M. Brooke Bernhardt, Mark Zobeck, Olga A. Taylor, M. Monica Gramatges, Eric S. Schafer +5 more

Novel and replicated clinical and genetic risk factors for toxicity from high‐dose methotrexate in pediatric acute lymphoblastic leukemia

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2023)10.1002/phar.2779

N/A

0DataRank · unranked

11 citations

M. Brooke Bernhardt, Kala Y. Kamdar, Karen R. Rabin, Philip J. Lupo, Michael E. Scheurer +1 more

Methotrexate Scarcity Among Children’s Oncology Group Institutions: Results of a Multinational Survey

The Oncologist(2023)10.1093/oncolo/oyad323

N/A

0DataRank · unranked

8 citations

Olga Militano, Andrew Ostrenga, M. Brooke Bernhardt, Brittany M. Lee, Yoram Unguru +1 more

Children's Oncology Group's 2023 blueprint for research: Pharmacy

Pediatric Blood & Cancer(2023)10.1002/pbc.30581

N/A

0DataRank · unranked

1 citations

Jennifer Thackray, Ha‐Mill H. McLearan, Kevin M. Mulieri, Elizabeth K. Bisaccia, Olga Militano +3 more

Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae165

N/A

0DataRank · unranked

0 citations

Teresa Rushing, Kristine R. Crews, Colleen Annesley, Susan I. Colace, Nicole Kaiser +14 more

Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene

Pediatric Blood & Cancer(2021)10.1002/pbc.29036

N/A

0DataRank · unranked

10 citations

M. Brooke Bernhardt, Kala Y. Kamdar, Karen R. Rabin, Philip J. Lupo, Michael E. Scheurer +1 more

Delayed excretion of high‐dose methotrexate in pediatric acute leukemia correlates with laxative and constipation management

Pediatric Blood & Cancer(2024)10.1002/pbc.31377

N/A

0DataRank · unranked

0 citations

Ashley Chavana, Ankona Banerjee, Mark Zobeck, Eric S. Schafer, Karen R. Rabin +10 more